课题基金 / 基金详情

Steroids and Stem Cell in Carcinogenesis

Steroids and Stem Cell in Carcinogenesis
类固醇和干细胞在致癌作用中的作用
批准号:
6726568
负责人:
DORIS Mangiaracina BENBROOK
金额:
$7.33万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-30 至 2005-08-31

项目摘要

项目成果

DORIS Mangiaracina BENBROOK的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Organotypic cultures are tissue culture models that mimic in vivo tissue architecture through manipulation of epithelial and stromal cells within and on top of an extracellular matrix. These models incorporate aspects of cell-matrix and epithelial-stromal interactions that cannot be evaluated in monolayer cultures. They can be used to evaluate monoclonal colonies, whereas individual xenograft tumors in animals are established from millions of cells. Colonies in organotypic culture therefore, more accurately mimic tumorigenesis than animal xenografts. Organotypic cultures can be more readily genetically and chemically manipulated than animal models, allowing increased numbers of experiments and less cost. They cannot replace animal models however, because they do not incorporate metabolic, physiologic and immunologic effects. Thus organotypic cultures can potentially be used to screen and improve chemoprevention agents prior to testing in animal models. In addition, they provide opportunities to evaluated hypothesis driven research on carcinogenesis and chemoprevention. We developed organotypic models of normal human endometrium, benign human ovarian tissue, and human borderline ovarian tumors of low malignant potential (LMP). The objective of this project is to further develop these organotypic models into models of carcinogenesis that can be used to study the processes of carcinogenesis and chemoprevention. The experiments proposed will evaluate the interaction of aromatic hydrocarbons, estrogen, progesterone, tamoxifen, differentiation and adult stem cells in endometrial and ovarian carcinogenesis. Our future goals will be to validate these models and to use them in our efforts to develop low-toxicity retinoids, heteroarotinoids, for chemoprevention. This research will enhance our understanding of the process of carcinogenesis and chemoprevention, which could ultimately translate into strategies and pharmaceuticals for prevention of cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 1: Targeting HSPA Proteins in Advanced and Recurrent Endometrial Cancer Therapy
  • 批准号:
    10711636
  • 项目类别:
  • 资助金额:
    $40.34万
  • 财政年份:
    2023
  • 负责人:
    DORIS Mangiaracina BENBROOK
  • 依托单位:
Route 66 Endometrial Cancer SPORE
  • 批准号:
    10711634
  • 项目类别:
  • 资助金额:
    $238.47万
  • 财政年份:
    2023
  • 负责人:
    DORIS Mangiaracina BENBROOK
  • 依托单位:
Gynecologic Cancers Research Program
Gynecologic Cancers Research Program